Scarica l'app Stockscreener
190.01
0.57%
1.07
Dopo l'orario di chiusura:
189.65
-0.36
-0.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
Moderna stock after-hours at EUR 170.09: plus 0.70 percent versus the prior close - AD HOC NEWS
Moderna Stock Is Trending: What's Going On? - Benzinga
Top Healthcare Stocks To Watch TodayOctober 1st - MarketBeat
Moderna loses US government license defense in Northwestern patent case - reuters.com
Why Citi Is Sounding the Alarm on Moderna Stock - Barchart.com
Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water - Yahoo Finance
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water - 247wallst.com
Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test - Simply Wall Street
The Escalator: Moderna, Hatteras Venture Partners, PhRMA and more - Medical Marketing and Media
Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet - FinancialContent
Moderna adds COO role. Moderna stock falls 1.40 percent - AD HOC NEWS
Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today’s Market - Barron's
Moderna, Inc. Announces Management Changes - marketscreener.com
Why Moderna (MRNA) Shares Are Falling Today - Yahoo Finance
This Analyst Just Downgraded Moderna Stock. Here's Why. - Yahoo Finance
Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline - Barron's
Moderna Stock Slumps as Citi Says It’s Time to Sell After 500% Rally This Year - Investopedia
Moderna Shares Reverse Weakness, Rise Over 3% After Key Trading Signal - Benzinga
Citi delivers major verdict after Moderna’s remarkable 703% run - thestreet.com
Prediction: Moderna Stock Will Soar 100% by 2030 - Yahoo Finance
Prediction: Moderna Stock Will Soar 100% by 2030 - The Motley Fool
What's Going On With Moderna Stock on Wednesday? - Benzinga
Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? - Zacks Investment Research
Moderna Tumbles as Citi Advises Selling Following 600% Rally - Bloomberg.com
Moderna (MRNA) Options Traders Turn Moderately Bearish Amid Pric - GuruFocus
Moderna (NASDAQ:MRNA) Shares Gap DownHere's Why - MarketBeat
Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter - Barron's
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains - MarketWatch
Moderna (MRNA) Shares Drop 6.88% Premarket After Citi Downgrade Citing Valuation Concerns - GuruFocus
Moderna Inc Stock (MRNA) Opened Down by 6.27% on Sep 30: Key Drivers Unveiled - TradingKey
Three biotech updates, including accusations of theft and and a new lobbying leader - statnews.com
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat - Yahoo Finance
Target upgraded, Moderna downgraded: Wall Street's top analyst calls - Yahoo Finance
MRNA Stock Downgraded As Valuation Fears Eclipse Cancer Win - StocksToTrade
MRNA Stock Downgraded As Valuation Fears Clash With Trial Success - timothysykes.com
Moderna (MRNA) Shares Fall Premarket After Citi Downgrades to Se - GuruFocus
MRNA Stock Falls Premarket After Citi Downgrade: Analyst Says Valuation Looks Stretched Despite Cancer Vaccine Momentum - Yahoo Finance
Premarket movers: Micron; Boeing rises, Moderna slides - Yahoo Finance
Moderna Names Juan Andres as COO - marketscreener.com
Moderna stock slips as Citi cuts to Sell (MRNA:NASDAQ) - Seeking Alpha
Moderna: Citi says oncology optimism is priced in, cuts rating to sell - Yahoo! Finance Canada
Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic” - TipRanks
Moderna names Juan Andres chief operating officer - TradingView
Moderna names Juan Andres as chief operating officer - Investing.com
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology - ACCESS Newswire
Moderna, Inc. (MRNA) Adds COO; Andres Returns, Collins Retires - TradingView
Citigroup Downgrades Moderna to Sell From Neutral, Adjusts Price Target to $80 From $60 - marketscreener.com
Moderna Sets Another Fresh 52-Week High: What's Happening? - Benzinga
Bayer Advances Patent Suit Over Moderna, Pfizer Covid Vaccines - Bloomberg Law News
Moderna And Merck: The Intismeran Readout That Was Worth $86 Billion (NASDAQ:MRNA) - Seeking Alpha
Precision Trading with Moderna Inc. (MRNA) Risk Zones - Stock Traders Daily
Moderna (NASDAQ:MRNA) Sets New 12-Month HighHere's What Happened - MarketBeat
Moderna stock hits 52-week high at 202.69 USD - Investing.com
Pfizer and Moderna Lose Bids to Escape Bayer mRNA Patent Lawsuits - Lawyer Monthly
Bayer's COVID Vax IP Suits Against Moderna, Pfizer Survive - Law360
Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuits (PFE:NYSE) - Seeking Alpha
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit - reuters.com
Moderna Inc (MRNA): What a GF Score of 57 Says About the Stock - GuruFocus
Up Over 550% in 2026, Is It Too Late to Buy Moderna Stock? - Yahoo Finance
The first mRNA flu vaccine is now available for older adults. Here’s what to know - KCRA
Biotech Stocks To Follow TodaySeptember 27th - MarketBeat
Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on Septem - GuruFocus
Moderna | mRNA Vaccines, Cancer Therapies, & History - Britannica
MODERNA INC (MRNA-USD.SW) - Yahoo! Finance Canada
Top Healthcare Stocks To ConsiderSeptember 26th - MarketBeat
Moderna Stock (MRNA) Opinions on Cancer Vaccine Phase 3 Success - Quiver Quantitative
Moderna CEO’s Realistic Approach to Innovation - WSJ
Top Biotech Stocks To Add to Your WatchlistSeptember 26th - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Moderna Inc Lobbyists, 2026 - OpenSecrets
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Stock Traders Purchase Large Volume of Call Options on Moderna (NASDAQ:MRNA) - MarketBeat
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - Yahoo Finance
0.05%
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):